ArticleJournal of family medicine and primary care2025
Serum LDL level as an indirect marker of erectile dysfunction in male CAD patients.
Article in Journal of family medicine and primary care, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Erectile dysfunction (ED) is a prevalent condition among male patients with coronary artery disease (CAD), often reflecting underlying vascular problems. Recent studies suggest that serum low-density lipoprotein (LDL) levels, a key factor in atherosclerosis, might serve as an indirect marker of ED in this population. Aims & Objectives: The aim of our study is to analyse correlation between serum LDL level and severity of erectile dysfunction. To assess the prevalence of erectile dysfunction in male CAD patients. To evaluate other potential risk factors contributing to erectile dysfunction in male CAD patients. Method: From September 2022 to August 2023, 240 CAD patients were analysed for organic ED with the help of IIEF-5 score, and their lipid profile (Cholesterol, Triglyceride, HDL, LDL) were compared. Results: Mean age in the study group is 47.61± 7.82 years. The overall prevalence of ED among MALE CAD patients was found out to be 73%, with Mean IIEF-5 score of 16.9 with SD 4.89. LDL cholesterol level had a positive correlation with Severity of ED (p value 4.88×10-16, r=-0.7052, r2=0.49). Mean LDL 95.83mg/dl with a standard deviation of 31.37. Serum cholesterol level had a positive correlation with Severity of ED (p value= 2.84×10-9). Mean Cholesterol level is 165.5mg/dl with a SD of 38.66. Conclusion: Treatment for hyperlipidaemia plays a crucial role in preventing ED, as evidenced by the impact of total cholesterol and LDL in particular on men's erectile function. This highlights the need for a comprehensive approach to managing ED patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.